Clearmind Medicine Common Stock Alpha and Beta Analysis
| CMND Stock | USD 1.44 0.05 3.36% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Clearmind Medicine Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Clearmind Medicine over a specified time horizon. Remember, high Clearmind Medicine's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Clearmind Medicine's market risk premium analysis include:
Beta 0.36 | Alpha 0.57 | Risk 8.58 | Sharpe Ratio 0.0482 | Expected Return 0.41 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Clearmind |
Clearmind Medicine Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Clearmind Medicine market risk premium is the additional return an investor will receive from holding Clearmind Medicine long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Clearmind Medicine. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Clearmind Medicine's performance over market.| α | 0.57 | β | 0.36 |
Clearmind Medicine expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Clearmind Medicine's Buy-and-hold return. Our buy-and-hold chart shows how Clearmind Medicine performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Clearmind Medicine Market Price Analysis
Market price analysis indicators help investors to evaluate how Clearmind Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clearmind Medicine shares will generate the highest return on investment. By understating and applying Clearmind Medicine stock market price indicators, traders can identify Clearmind Medicine position entry and exit signals to maximize returns.
Clearmind Medicine Return and Market Media
The median price of Clearmind Medicine for the period between Fri, Oct 11, 2024 and Thu, Jan 9, 2025 is 1.39 with a coefficient of variation of 8.35. The daily time series for the period is distributed with a sample standard deviation of 0.12, arithmetic mean of 1.4, and mean deviation of 0.09. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mu | 12/16/2024 |
2 | Why Is Penny Stock Clearmind Gaining Today | 12/24/2024 |
3 | Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office | 01/02/2025 |
About Clearmind Medicine Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Clearmind or other stocks. Alpha measures the amount that position in Clearmind Medicine Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2024 | 2025 (projected) | Net Debt To EBITDA | 0.0145 | 0.45 | 0.52 | 0.49 | Intangibles To Total Assets | 0.16 | 0.02 | 0.0229 | 0.0218 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Clearmind Medicine in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Clearmind Medicine's short interest history, or implied volatility extrapolated from Clearmind Medicine options trading.
Build Portfolio with Clearmind Medicine
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Clearmind Medicine Backtesting, Clearmind Medicine Valuation, Clearmind Medicine Correlation, Clearmind Medicine Hype Analysis, Clearmind Medicine Volatility, Clearmind Medicine History and analyze Clearmind Medicine Performance. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Clearmind Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.